Dermatology · Orangeburg, NY
NPI
1295707461
Since 2006
Specialty
Dermatology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
60 Dutch Hill Rd, Suite 18
Orangeburg, NY, 10962
Phone (845) 359-4770
Groups this clinician bills Medicare through
Medicare paid, 2024
$443K
10,868 services
Medicare patients, 2024
1,525
Average age 76
Drug cost, 2024
$43K
549 prescriptions
Company payments, 2025
$727
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joshua P Fogelman was code 17003 (destruction skin lesion), 2,860 times for 488 patients. In total Joshua P Fogelman billed 10,868 services in 33 codes, and Medicare paid $443K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-06-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 2,860 | 488 | $6.39 | $18K |
| 99213 Office E&M - Established | Office | 2,150 | 1,305 | $81.11 | $174K |
| 17000 Destruction Skin Lesion | Office | 1,128 | 680 | $53.03 | $60K |
| 11102 Skin Biopsy | Office | 539 | 450 | $92.52 | $50K |
| 96900 Skin | Office | 538 | 11 | $24.21 | $13K |
| 17110 Destruction Skin Lesion | Office | 513 | 375 | $103.46 | $53K |
| 99211 Office E&M - Established | Office | 481 | 11 | $21.85 | $11K |
| 11103 Skin Biopsy | Office | 155 | 110 | $50.39 | $7,810 |
| 99203 Office E&M - New | Office | 135 | 135 | $100.69 | $14K |
| 99212 Office E&M - Established | Office | 124 | 112 | $51.98 | $6,445 |
| 10040 Removal or Shaving of Skin Growth | Office | 57 | 50 | $107.00 | $6,099 |
| 99214 Office E&M - Established | Office | 44 | 30 | $120.06 | $5,283 |
| 17262 Destruction Skin Lesion | Office | 36 | 36 | $179.26 | $6,454 |
| 69100 Other Organ Systems | Office | 26 | 24 | $79.28 | $2,061 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 26 | 15 | $0.76 | $19.65 |
By year: 2022 $438K for 10,284 services; 2023 $445K for 10,421 services; 2024 $443K for 10,868 services.
Medicare prescription drug claims, 2024
In 2024, the drug Joshua P Fogelman prescribed most often to Medicare patients was Triamcinolone Acetonide, with 73 prescriptions and refills. In total Joshua P Fogelman wrote 549 Medicare prescriptions that cost $43K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 73 | 77 | 61 | $439 |
| Hydrocortisone Generic | 63 | 63 | 59 | $298 |
| Ketoconazole Generic | 61 | 64 | 47 | $988 |
| Azelaic Acid Generic | 48 | 54 | 23 | $4,718 |
| Mupirocin Generic | 38 | 38 | 29 | $261 |
| Ciclopirox Ciclopirox Olamine | 29 | 30 | 23 | $583 |
| Metronidazole Generic | 28 | 30 | 12 | $1,892 |
| Fluocinolone Acetonide Generic | 22 | 22 | 17 | $1,026 |
| Fluocinonide Generic | 21 | 21 | 18 | $902 |
| Ciclopirox Generic | 15 | 17 | 12 | $695 |
| Alclometasone Dipropionate Generic | 14 | 14 | 14 | $316 |
| Finacea Azelaic Acid | 14 | 15 | Under 11 | $5,824 |
| Desonide Generic | 13 | 13 | 12 | $802 |
| Mometasone Furoate Generic | 12 | 13 | 12 | $221 |
| Clobetasol Propionate Generic | 12 | 12 | Under 11 | $788 |
Brand drugs: 48 claims; generic drugs: 501 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joshua P Fogelman $727 ($727 in general payments such as food, travel and fees) from 17 companies. The largest payer was Arcutis Biotherapeutics, Inc. with $106.
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. ARQT | 6 | $106 |
| Amgen Inc. AMGN | 3 | $90.49 |
| Pfizer Inc. PFE | 5 | $79.6 |
| Galderma Laboratories, L.P. GALD.SW | 3 | $65.39 |
| Organon LLC OGN | 6 | $53.12 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $40.81 |
| Biofrontera Inc. | 2 | $39.46 |
| Janssen Biotech, Inc. JNJ | 1 | $36.73 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $35.32 |
| Genzyme Corporation SNY | 1 | $33.15 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.